JAMDA
Volume 10, Issue 6 , Pages 381-393 , July 2009

Apathy: A Common Psychiatric Syndrome in the Elderly

  • Shinya Ishii, MD

      Affiliations

    • GRECC, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA
    • Corresponding Author InformationAddress correspondence to Shinya Ishii, MD, GRECC, Veterans Affairs Greater Los Angeles Healthcare System, 11301 Wilshire Boulevard, Building 220, Room 302 Los Angeles, CA 90073.
    • ,
  • Nancy Weintraub, MD

      Affiliations

    • Sepulveda Campus Greater Los Angeles Veterans Affairs Health Care System, Los Angeles, CA
    • David Geffen School of Medicine at UCLA, Los Angeles, CA
    • ,
  • James R. Mervis, MD

      Affiliations

    • Sepulveda Campus Greater Los Angeles Veterans Affairs Health Care System, Los Angeles, CA
    • David Geffen School of Medicine at UCLA, Los Angeles, CA

References 

  1. Marin RS. Apathy: A neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci. 1991;3:243–254
  2. Levy R, Czernecki V. Apathy and the basal ganglia. J Neurol. 2006;253:VII54–VII61
  3. van Reekum R, Stuss DT, Ostrander L. Apathy: Why care?. J Neuropsychiatry Clin Neurosci. 2005;17:7–19
  4. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition ed.. Arlington, VA: American Psychiatric Publishing, Inc.; 2004;
  5. Levy ML, Cummings JL, Fairbanks LA, et al. Apathy is not depression. J Neuropsychiatry Clin Neurosci. 1998;10:314–319
  6. Landes AM, Sperry SD, Strauss ME, Geldmacher DS. Apathy in Alzheimer's disease. J Am Geriatr Soc. 2001;49:1700–1707
  7. Starkstein SE, Jorge R, Mizrahi R, Robinson RG. A prospective longitudinal study of apathy in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2006;77:8–11
  8. Ready RE, Ott BR, Grace J, Cahn-Weiner DA. Apathy and executive dysfunction in mild cognitive impairment and Alzheimer disease. Am J Geriatr Psychiatry. 2003;11:222–228
  9. Rabkin JG, Ferrando SJ, van Gorp W, et al. Relationships among apathy, depression, and cognitive impairment in HIV/AIDS. J Neuropsychiatry Clin Neurosci. 2000;12:451–457
  10. Lavretsky H, Lesser IM, Wohl M, et al. Clinical and neuroradiologic features associated with chronicity in late-life depression. Am J Geriatr Psychiatry. 1999;7:309–316
  11. Marin RS, Firinciogullari S, Biedrzycki RC. The sources of convergence between measures of apathy and depression. J Affect Disord. 1993;28:117–124
  12. Piamarta F, Iurlaro S, Isella V, et al. Unconventional affective symptoms and executive functions after stroke in the elderly. Arch Gerontol Geriatr Suppl. 2004;315–323
  13. Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res. 1991;38:143–162
  14. Starkstein SE, Petracca G, Chemerinski E, Kremer J. Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry. 2001;158:872–877
  15. Starkstein SE, Fedoroff JP, Price TR, et al. Apathy following cerebrovascular lesions. Stroke. 1993;24:1625–1630
  16. Starkstein SE, Ingram L, Garau ML, Mizrahi R. On the overlap between apathy and depression in dementia. J Neurol Neurosurg Psychiatry. 2005;76:1070–1074
  17. Andersson S, Krogstad JM, Finset A. Apathy and depressed mood in acquired brain damage: Relationship to lesion localization and psychophysiological reactivity. Psychol Med. 1999;29:447–456
  18. Starkstein SE, Mizrahi R, Garau L. Specificity of symptoms of depression in Alzheimer disease: A longitudinal analysis. Am J Geriatr Psychiatry. 2005;13:802–807
  19. Holthoff VA, Beuthien-Baumann B, Kalbe E, et al. Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression. Biol Psychiatry. 2005;57:412–421
  20. Mehta M, Whyte E, Lenze E, et al. Depressive symptoms in late life: associations with apathy, resilience and disability vary between young-old and old-old. Int J Geriatr Psychiatry. 2008;23:238–243
  21. Krishnan KR, Hays JC, Tupler LA, et al. Clinical and phenomenological comparisons of late-onset and early-onset depression. Am J Psychiatry. 1995;152:785–788
  22. Hoehn-Saric R, Lipsey JR, McLeod DR. Apathy and indifference in patients on fluvoxamine and fluoxetine. J Clin Psychopharmacol. 1990;10:343–345
  23. Settle EC. Antidepressant drugs: Disturbing and potentially dangerous adverse effects. J Clin Psychiatry. 1998;59:25–30discussion 40–22
  24. Fava M, Graves LM, Benazzi F, et al. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. J Clin Psychiatry. 2006;67:1754–1759
  25. Wongpakaran N, van Reekum R, Wongpakaran T, Clarke D. Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: A case-control study. Ann Gen Psychiatry. 2007;6:7
  26. Alexopoulos GS. Depression in the elderly. Lancet. 2005;365:1961–1970
  27. Benoit M, Andrieu S, Lechowski L, et al. Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription. Int J Geriatr Psychiatry. 2008;23:409–414
  28. Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology. 1996;46:130–135
  29. Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology. 1996;47:1184–1189
  30. Kaufer DI, Cummings JL, Christine D, et al. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: The Neuropsychiatric Inventory Caregiver Distress Scale. J Am Geriatr Soc. 1998;46:210–215
  31. Benoit M, Dygai I, Migneco O, et al. Behavioral and psychological symptoms in Alzheimer's disease. Relation between apathy and regional cerebral perfusion. Dement Geriatr Cogn Disord. 1999;10:511–517
  32. Aharon-Peretz J, Kliot D, Tomer R. Behavioral differences between white matter lacunar dementia and Alzheimer's disease: A comparison on the neuropsychiatric inventory. Dement Geriatr Cogn Disord. 2000;11:294–298
  33. Aarsland D, Cummings JL, Larsen JP. Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease. Int J Geriatr Psychiatry. 2001;16:184–191
  34. Pang FC, Chow TW, Cummings JL, et al. Effect of neuropsychiatric symptoms of Alzheimer's disease on Chinese and American caregivers. Int J Geriatr Psychiatry. 2002;17:29–34
  35. Mirakhur A, Craig D, Hart DJ, et al. Behavioural and psychological syndromes in Alzheimer's disease. Int J Geriatr Psychiatry. 2004;19:1035–1039
  36. Senanarong V, Poungvarin N, Jamjumras P, et al. Neuropsychiatric symptoms, functional impairment and executive ability in Thai patients with Alzheimer's disease. Int Psychogeriatr. 2005;17:81–90
  37. Srikanth S, Nagaraja AV, Ratnavalli E. Neuropsychiatric symptoms in dementia—frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia. J Neurol Sci. 2005;236:43–48
  38. Fuh JL, Wang SJ, Cummings JL. Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia. J Neurol Neurosurg Psychiatry. 2005;76:1337–1341
  39. Monastero R, Mariani E, Camarda C, et al. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. Acta Psychiatr Scand. 2006;113:59–63
  40. Hwang TJ, Masterman DL, Ortiz F, et al. Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alzheimer Dis Assoc Disord. 2004;18:17–21
  41. Benoit M, Robert PH, Staccini P, et al. One-year longitudinal evaluation of neuropsychiatric symptoms in Alzheimer's disease. The REAL.FR Study. J Nutr Health Aging. 2005;9:95–99
  42. Thomas P, Clement JP, Hazif-Thomas C, Leger JM. Family, Alzheimer's disease and negative symptoms. Int J Geriatr Psychiatry. 2001;16:192–202
  43. Robert PH, Darcourt G, Koulibaly MP, et al. Lack of initiative and interest in Alzheimer's disease: A single photon emission computed tomography study. Eur J Neurol. 2006;13:729–735
  44. Devanand DP, Brockington CD, Moody BJ, et al. Behavioral syndromes in Alzheimer's disease. Int Psychogeriatr. 1992;4:161–184
  45. Landes AM, Sperry SD, Strauss ME. Prevalence of apathy, dysphoria, and depression in relation to dementia severity in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 2005;17:342–349
  46. Stout JC, Wyman MF, Johnson SA, et al. Frontal behavioral syndromes and functional status in probable Alzheimer disease. Am J Geriatr Psychiatry. 2003;11:683–686
  47. Bozzola FG, Gorelick PB, Freels S. Personality changes in Alzheimer's disease. Arch Neurol. 1992;49:297–300
  48. Lyketsos CG, Steinberg M, Tschanz JT, et al. Mental and behavioral disturbances in dementia: Findings from the Cache County Study on Memory in Aging. Am J Psychiatry. 2000;157:708–714
  49. Steinberg M, Sheppard JM, Tschanz JT, et al. The incidence of mental and behavioral disturbances in dementia: The cache county study. J Neuropsychiatry Clin Neurosci. 2003;15:340–345
  50. Tatsch MF, Bottino CM, Azevedo D, et al. Neuropsychiatric symptoms in Alzheimer disease and cognitively impaired, nondemented elderly from a community-based sample in Brazil: Prevalence and relationship with dementia severity. Am J Geriatr Psychiatry. 2006;14:438–445
  51. Robert PH, Berr C, Volteau M, et al. Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease: A one-year follow-up study. Clin Neurol Neurosurg. 2006;108:733–736
  52. Lyketsos CG, Lopez O, Jones B, et al. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. JAMA. 2002;288:1475–1483
  53. Zgaljardic DJ, Borod JC, Foldi NS, et al. Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease. Cogn Behav Neurol. 2007;20:184–192
  54. Starkstein SE, Mayberg HS, Preziosi TJ, et al. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1992;4:134–139
  55. Sockeel P, Dujardin K, Devos D, et al. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: Validation in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2006;77:579–584
  56. Aarsland D, Litvan I, Larsen JP. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2001;13:42–49
  57. Dujardin K, Sockeel P, Devos D, et al. Characteristics of apathy in Parkinson's disease. Mov Disord. 2007;22:778–784
  58. Pluck GC, Brown RG. Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2002;73:636–642
  59. Isella V, Melzi P, Grimaldi M, et al. Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease. Mov Disord. 2002;17:366–371
  60. Aarsland D, Larsen JP, Lim NG, et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999;67:492–496
  61. Borroni B, Turla M, Bertasi V, et al. Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes. Arch Gerontol Geriatr. 2008;47:53–61
  62. Litvan I, Paulsen JS, Mega MS, Cummings JL. Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Arch Neurol. 1998;55:1313–1319
  63. Litvan I, Cummings JL, Mega M. Neuropsychiatric features of corticobasal degeneration. J Neurol Neurosurg Psychiatry. 1998;65:717–721
  64. Pasquier F, Lebert F, Lavenu I, Guillaume B. The clinical picture of frontotemporal dementia: Diagnosis and follow-up. Dement Geriatr Cogn Disord. 1999;10:10–14
  65. Diehl-Schmid J, Pohl C, Perneczky R, et al. Behavioral disturbances in the course of frontotemporal dementia. Dement Geriatr Cogn Disord. 2006;22:352–357
  66. Diaz-Olavarrieta C, Cummings JL, Velazquez J. Garcia de la Cadena C. Neuropsychiatric manifestations of multiple sclerosis. J Neuropsychiatry Clin Neurosci. 1999;11:51–57
  67. Figved N, Klevan G, Myhr KM, et al. Neuropsychiatric symptoms in patients with multiple sclerosis. Acta Psychiatr Scand. 2005;112:463–468
  68. Hama S, Yamashita H, Shigenobu M, et al. Depression or apathy and functional recovery after stroke. Int J Geriatr Psychiatry. 2007;22:1046–1051
  69. Brodaty H, Sachdev PS, Withall A, et al. Frequency and clinical, neuropsychological and neuroimaging correlates of apathy following stroke—the Sydney Stroke Study. Psychol Med. 2005;35:1707–1716
  70. Glodzik-Sobanska L, Slowik A, Kieltyka A, et al. Reduced prefrontal N-acetylaspartate in stroke patients with apathy. J Neurol Sci. 2005;238:19–24
  71. van der Mast RC, Vinkers DJ, Stek ML, et al. Vascular disease and apathy in old age. The Leiden 85-plus Study. Int J Geriatr Psychiatry. 2008;23:266–271
  72. Al-Adawi S, Dorvlo AS, Burke DT, et al. Apathy and depression in cross-cultural survivors of traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2004;16:435–442
  73. Kant R, Duffy JD, Pivovarnik A. Prevalence of apathy following head injury. Brain Inj. 1998;12:87–92
  74. Grossman AB, Woolley-Levine S, Bradley WG, Miller RG. Detecting neurobehavioral changes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:56–61
  75. Zuidema SU, Derksen E, Verhey FR, Koopmans RT. Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia. Int J Geriatr Psychiatry. 2007;22:632–638
  76. Pitkala KH, Laurila JV, Strandberg TE, Tilvis RS. Behavioral symptoms and the administration of psychotropic drugs to aged patients with dementia in nursing homes and in acute geriatric wards. Int Psychogeriatr. 2004;16:61–74
  77. Margallo-Lana M, Swann A, O'Brien J, et al. Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments. Int J Geriatr Psychiatry. 2001;16:39–44
  78. Wood S, Cummings JL, Hsu MA, et al. The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement. Am J Geriatr Psychiatry. 2000;8:75–83
  79. Wagner AW, Teri L, Orr-Rainey N. Behavior problems of residents with dementia in special care units. Alzheimer Dis Assoc Disord. 1995;9:121–127
  80. Hart DJ, Craig D, Compton SA, et al. A retrospective study of the behavioural and psychological symptoms of mid and late phase Alzheimer's disease. Int J Geriatr Psychiatry. 2003;18:1037–1042
  81. Steinberg M, Tschanz JT, Corcoran C, et al. The persistence of neuropsychiatric symptoms in dementia: The Cache County Study. Int J Geriatr Psychiatry. 2004;19:19–26
  82. Strauss ME, Sperry SD. An informant-based assessment of apathy in Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol. 2002;15:176–183
  83. Binetti G, Mega MS, Magni E, et al. Behavioral disorders in Alzheimer disease: A transcultural perspective. Arch Neurol. 1998;55:539–544
  84. Craig AH, Cummings JL, Fairbanks L, et al. Cerebral blood flow correlates of apathy in Alzheimer disease. Arch Neurol. 1996;53:1116–1120
  85. Onyike CU, Sheppard JM, Tschanz JT, et al. Epidemiology of apathy in older adults: The Cache County Study. Am J Geriatr Psychiatry. 2007;15:365–375
  86. Gerritsen DL, Jongenelis K, Steverink N, et al. Down and drowsy? Do apathetic nursing home residents experience low quality of life?. Aging Ment Health. 2005;9:135–141
  87. Craig D, Mirakhur A, Hart DJ, et al. A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease. Am J Geriatr Psychiatry. 2005;13:460–468
  88. Benoit M, Clairet S, Koulibaly PM, et al. Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's disease. Int J Geriatr Psychiatry. 2004;19:864–869
  89. Robert PH, Clairet S, Benoit M, et al. The apathy inventory: Assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatr Psychiatry. 2002;17:1099–1105
  90. Rosen HJ, Allison SC, Schauer GF, et al. Neuroanatomical correlates of behavioural disorders in dementia. Brain. 2005;128:2612–2625
  91. Feil D, Razani J, Boone K, Lesser I. Apathy and cognitive performance in older adults with depression. Int J Geriatr Psychiatry. 2003;18:479–485
  92. Janzing JG, Naarding P, Eling PA. Depressive symptom quality and neuropsychological performance in dementia. Int J Geriatr Psychiatry. 2005;20:479–484
  93. Robert PH, Berr C, Volteau M, et al. Neuropsychological performance in mild cognitive impairment with and without apathy. Dement Geriatr Cogn Disord. 2006;21:192–197
  94. McPherson S, Fairbanks L, Tiken S, et al. Apathy and executive function in Alzheimer's disease. J Int Neuropsychol Soc. 2002;8:373–381
  95. Andersson S, Bergedalen AM. Cognitive correlates of apathy in traumatic brain injury. Neuropsychiatry Neuropsychol Behav Neurol. 2002;15:184–191
  96. Freels S, Cohen D, Eisdorfer C, et al. Functional status and clinical findings in patients with Alzheimer's disease. J Gerontol. 1992;47:M177–M182
  97. Boyle PA, Malloy PF, Salloway S, et al. Executive dysfunction and apathy predict functional impairment in Alzheimer disease. Am J Geriatr Psychiatry. 2003;11:214–221
  98. Zawacki TM, Grace J, Paul R, et al. Behavioral problems as predictors of functional abilities of vascular dementia patients. J Neuropsychiatry Clin Neurosci. 2002;14:296–302
  99. Steffens DC, Hays JC, Krishnan KR. Disability in geriatric depression. Am J Geriatr Psychiatry. 1999;7:34–40
  100. de Vugt ME, Stevens F, Aalten P, et al. Behavioural disturbances in dementia patients and quality of the marital relationship. Int J Geriatr Psychiatry. 2003;18:149–154
  101. Derouesne C, Thibault S, Lagha-Pierucci S, et al. Decreased awareness of cognitive deficits in patients with mild dementia of the Alzheimer type. Int J Geriatr Psychiatry. 1999;14:1019–1030
  102. Starkstein SE, Sabe L, Chemerinski E, et al. Two domains of anosognosia in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1996;61:485–490
  103. Samus QM, Rosenblatt A, Steele C, et al. The association of neuropsychiatric symptoms and environment with quality of life in assisted living residents with dementia. Gerontologist. 2005;45:19–26
  104. van Dijk PT, Dippel DW, Habbema JD. A behavioral rating scale as a predictor for survival of demented nursing home patients. Arch Gerontol Geriatr. 1994;18:101–113
  105. Chaturvedi SK, Sarmukaddam SB. Prediction of outcome in depression by negative symptoms. Acta Psychiatr Scand. 1986;74:183–186
  106. Padala PR, Desouza CV, Almeida S, et al. The impact of apathy on glycemic control in diabetes: A cross-sectional study. Diabetes Res Clin Pract. 2008;79:37–41
  107. Tekin S, Cummings JL. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: An update. J Psychosom Res. 2002;53:647–654
  108. Bonelli RM, Cummings JL. Frontal-subcortical circuitry and behavior. Dialogues Clin Neurosci. 2007;9:141–151
  109. Marshall GA, Fairbanks LA, Tekin S, et al. Neuropathologic correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord. 2006;21:144–147
  110. Tekin S, Mega MS, Masterman DM, et al. Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Ann Neurol. 2001;49:355–361
  111. Hama S, Yamashita H, Shigenobu M, et al. Post-stroke affective or apathetic depression and lesion location: Left frontal lobe and bilateral basal ganglia. Eur Arch Psychiatry Clin Neurosci. 2007;257:149–152
  112. Lavretsky H, Ballmaier M, Pham D, et al. Neuroanatomical characteristics of geriatric apathy and depression: A magnetic resonance imaging study. Am J Geriatr Psychiatry. 2007;15:386–394
  113. Apostolova LG, Akopyan GG, Partiali N, et al. Structural correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord. 2007;24:91–97
  114. Roth RM, Flashman LA, Saykin AJ, et al. Apathy in schizophrenia: Reduced frontal lobe volume and neuropsychological deficits. Am J Psychiatry. 2004;161:157–159
  115. Paul RH, Brickman AM, Navia B, et al. Apathy is associated with volume of the nucleus accumbens in patients infected with HIV. J Neuropsychiatry Clin Neurosci. 2005;17:167–171
  116. Starkstein SE, Sabe L, Vazquez S, et al. Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1997;63:66–73
  117. Lopez OL, Zivkovic S, Smith G, et al. Psychiatric symptoms associated with cortical-subcortical dysfunction in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 2001;13:56–60
  118. Remy P, Doder M, Lees A, et al. Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system. Brain. 2005;128:1314–1322
  119. Franceschi M, Anchisi D, Pelati O, et al. Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration. Ann Neurol. 2005;57:216–225
  120. Marshall GA, Monserratt L, Harwood D, et al. Positron emission tomography metabolic correlates of apathy in Alzheimer disease. Arch Neurol. 2007;64:1015–1020
  121. Migneco O, Benoit M, Koulibaly PM, et al. Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: A study in Alzheimer's disease and nondemented patients. Neuroimage. 2001;13:896–902
  122. Lanctot KL, Moosa S, Herrmann N, et al. A SPECT study of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord. 2007;24:65–72
  123. Benoit M, Koulibaly PM, Migneco O, et al. Brain perfusion in Alzheimer's disease with and without apathy: A SPECT study with statistical parametric mapping analysis. Psychiatry Res. 2002;114:103–111
  124. Ott BR, Noto RB, Fogel BS. Apathy and loss of insight in Alzheimer's disease: A SPECT imaging study. J Neuropsychiatry Clin Neurosci. 1996;8:41–46
  125. David R, Koulibaly M, Benoit M, et al. Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases. A SPECT study with partial volume effect correction. Clin Neurol Neurosurg. 2008;110:19–24
  126. Czernecki V, Pillon B, Houeto JL, et al. Motivation, reward, and Parkinson's disease: Influence of dopatherapy. Neuropsychologia. 2002;40:2257–2267
  127. Marin RS. Differential diagnosis and classification of apathy. Am J Psychiatry. 1990;147:22–30
  128. Starkstein SE, Garau ML, Cao A. Prevalence and clinical correlates of disinhibition in dementia. Cogn Behav Neurol. 2004;17:139–147
  129. Buettner L, Fitzsimmons S. Mixed behaviors in dementia: The need for a paradigm shift. J Gerontol Nurs. 2006;32:15–22
  130. Peters F, Perani D, Herholz K, et al. Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dement Geriatr Cogn Disord. 2006;21:373–379
  131. Inouye SK, Bogardus ST, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999;340:669–676
  132. Shapiro B, Mervis JR. Distinguishing delirium and dementia. Aging Health. 2007;3:33–48
  133. Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: The confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113:941–948
  134. Clarke DE, Van Reekum R, Patel J, et al. An appraisal of the psychometric properties of the Clinician version of the Apathy Evaluation Scale (AES-C). Int J Methods Psychiatr Res. 2007;16:97–110
  135. Clarke DE, Reekum R, Simard M, et al. Apathy in dementia: An examination of the psychometric properties of the apathy evaluation scale. J Neuropsychiatry Clin Neurosci. 2007;19:57–64
  136. Lueken U, Seidl U, Volker L, et al. Development of a short version of the Apathy Evaluation Scale specifically adapted for demented nursing home residents. Am J Geriatr Psychiatry. 2007;15:376–385
  137. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308–2314
  138. Cummings JL. The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology. 1997;48:S10–S16
  139. Stout JC, Ready RE, Grace J, et al. Factor analysis of the frontal systems behavior scale (FrSBe). Assessment. 2003;10:79–85
  140. Grace J, Stout JC, Malloy PF. Assessing frontal lobe behavioral syndromes with the frontal lobe personality scale. Assessment. 1999;6:269–284
  141. Tariot PN, Mack JL, Patterson MB, et al. The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry. 1995;152:1349–1357
  142. Reichman WE, Coyne AC, Amirneni S, et al. Negative symptoms in Alzheimer's disease. Am J Psychiatry. 1996;153:424–426
  143. Smith MM, Buckwalter KP. Behaviors associated with dementia: Whether resisting care or exhibiting apathy, an older adult with dementia is attempting communication. Nurses and other caregivers must learn to 'hear' this language. Am J Nurs. 2005;105:40–52
  144. Marin RS, Wilkosz PA. Disorders of diminished motivation. J Head Trauma Rehabil. 2005;20:377–388
  145. Politis AM, Vozzella S, Mayer LS, et al. A randomized, controlled, clinical trial of activity therapy for apathy in patients with dementia residing in long-term care. Int J Geriatr Psychiatry. 2004;19:1087–1094
  146. Holmes C, Knights A, Dean C, et al. Keep music live: Music and the alleviation of apathy in dementia subjects. Int Psychogeriatr. 2006;18:623–630
  147. Chapman SB, Weiner MF, Rackley A, et al. Effects of cognitive-communication stimulation for Alzheimer's disease patients treated with donepezil. J Speech Lang Hear Res. 2004;47:1149–1163
  148. Verkaik R, van Weert JC, Francke AL. The effects of psychosocial methods on depressed, aggressive and apathetic behaviors of people with dementia: A systematic review. Int J Geriatr Psychiatry. 2005;20:301–314
  149. Chatterjee A, Fahn S. Methylphenidate treats apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2002;14:461–462
  150. Keenan S, Mavaddat N, Iddon J, et al. Effects of methylphenidate on cognition and apathy in normal pressure hydrocephalus: A case study and review. Br J Neurosurg. 2005;19:46–50
  151. Campbell JJ, Duff JD. Treatment strategies in amotivated patients. Psychiatr Ann. 1997;27:44–49
  152. Padala PR, Petty F, Bhatia SC. Methylphenidate may treat apathy independent of depression. Ann Pharmacother. 2005;39:1947–1949
  153. Jansen IH, Olde Rikkert MG, Hulsbos HA, Hoefnagels WH. Toward individualized evidence-based medicine: Five “N of 1” trials of methylphenidate in geriatric patients. J Am Geriatr Soc. 2001;49:474–476
  154. Whitehouse PJ, Price DL, Struble RG, et al. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science. 1982;215:1237–1239
  155. Kaufer DI, Cummings JL, Christine D. Effect of tacrine on behavioral symptoms in Alzheimer's disease: An open-label study. J Geriatr Psychiatry Neurol. 1996;9:1–6
  156. Cummings JL, Nadel A, Masterman D, Cyrus PA. Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer's disease. J Geriatr Psychiatry Neurol. 2001;14:101–108
  157. Gauthier S, Feldman H, Hecker J, et al. Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease. Int Psychogeriatr. 2002;14:389–404
  158. Tariot PN, Cummings JL, Katz IR, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. J Am Geriatr Soc. 2001;49:1590–1599
  159. Seltzer B, Zolnouni P, Nunez M, et al. Efficacy of donepezil in early-stage Alzheimer disease: A randomized placebo-controlled trial. Arch Neurol. 2004;61:1852–1856
  160. Herrmann N, Rabheru K, Wang J, Binder C. Galantamine treatment of problematic behavior in Alzheimer disease: Post-hoc analysis of pooled data from three large trials. Am J Geriatr Psychiatry. 2005;13:527–534
  161. Edwards KR, Hershey L, Wray L, et al. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: A 12-week interim analysis. Dement Geriatr Cogn Disord. 2004;17:40–48
  162. McKeith I, Del Ser T, Spano P, et al. Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study. Lancet. 2000;356:2031–2036
  163. Cummings JL, Koumaras B, Chen M, Mirski D. Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: A 26-week, multicenter, open-label study. Am J Geriatr Pharmacother. 2005;3:137–148
  164. Van Reekum R, Bayley M, Garner S, et al. N of 1 study: Amantadine for the amotivational syndrome in a patient with traumatic brain injury. Brain Inj. 1995;9:49–53
  165. Guttman M, Jaskolka J. The use of pramipexole in Parkinson's disease: Are its actions D(3) mediated?. Parkinsonism Relat Disord. 2001;7:231–234
  166. Funkiewiez A, Ardouin C, Cools R, et al. Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease. Mov Disord. 2006;21:1656–1662
  167. Drapier D, Drapier S, Sauleau P, et al. Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?. J Neurol. 2006;253:1083–1091
  168. Schupbach WM, Chastan N, Welter ML, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5-year follow-up. J Neurol Neurosurg Psychiatry. 2005;76:1640–1644
  169. Funkiewiez A, Ardouin C, Caputo E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2004;75:834–839
  170. Castelli L, Lanotte M, Zibetti M, et al. Apathy and verbal fluency in STN-stimulated PD patients: An observational follow-up study. J Neurol. 2007;254:1238–1243
  171. Contarino MF, Daniele A, Sibilia AH, et al. Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2007;78:248–252
  172. Castelli L, Perozzo P, Zibetti M, et al. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits. Eur Neurol. 2006;55:136–144
  173. Corcoran C, Wong ML, O'Keane V. Bupropion in the management of apathy. J Psychopharmacol. 2004;18:133–135
  174. Marangell LB, Johnson CR, Kertz B, et al. Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: An open-label, flexible-dose study. J Clin Psychiatry. 2002;63:391–395
  175. Padala PR, Burke WJ, Bhatia SC. Modafinil therapy for apathy in an elderly patient. Ann Pharmacother. 2007;41:346–349
  176. Newburn G, Newburn D. Selegiline in the management of apathy following traumatic brain injury. Brain Inj. 2005;19:149–154
  177. Cummings JL, Schneider E, Tariot PN, Graham SM. Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. Neurology. 2006;67:57–63

PII: S1525-8610(09)00099-1

doi: 10.1016/j.jamda.2009.03.007

JAMDA
Volume 10, Issue 6 , Pages 381-393 , July 2009

Article Tools